🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

OmniAb, Inc.

OmniAb, Inc. logo
Market Cap: Medium
Employees: Low

Omni Ab platform

Omni Ab, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's platform leverages transgenic animals to generate human-like antibodies for therapeutic applications.

Tags: biotechnology, discovery platform, therapeutic antibodies, transgenic animals

Website

Leadership | Directors | News | Contact | Contact | Contact | Careers | About | About

Symbol: OABI

Recent Price: $3.56

Industry: Biotechnology

CEO: Mr. Matthew W. Foehr

Sector: Healthcare

Employees: 106

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 510 250 7800

Leadership

  • Matt Foehr, Chief Executive Officer
  • Kurt Gustafson, Chief Financial Officer
  • Charles Berkman, JD, Chief Legal Officer and Secretary
  • Yasmina Abdiche, PhD, Vice President, Exploratory Research
  • Laurel Bernstein, PhD, Vice President, Intellectual Property
  • Neil Castle, PhD, Vice President, Biology
  • Bob Chen, PhD, Sr. Director, Discovery Systems
  • Ellen Collarini, PhD, Sr. Director, Cell Biology
  • Bill Harriman, PhD, Sr. Vice President, Antibody Discovery
  • Christel Iffland, PhD, Sr. Vice President, Antibody Technologies
  • Shelley Izquierdo, PhD, Sr. Director, Antibody Discovery
  • Doug Krafte, PhD, Site Head – Durham, North Carolina Sr. Vice President, Ion Channels/Transporters
  • Phil Leighton, PhD, Fellow
  • Cia McCaffrey, Vice President, People and Talent
  • Anil Nair, PhD, Vice President, In Silico Discovery
  • Todd Pettingill, CFA, Vice President, Business Development and Strategy
  • Chris Silvia, PhD, Vice President, Data Sciences and Corporate IT
  • Eric Vajda, PhD, Vice President, Preclinical R&D
  • Marie-Cecile van de Lavoir, DVM, PhD, Sr. Vice President, Technical Operations and Genetics
  • Donna Ventura, CPA, Sr. Vice President, Corporate Controller
  • Carolyn R. Bertozzi, PhD, Board Member
  • Sarah Boyce, President and Chief Executive Officer
  • Jennifer Cochran, PhD, Board Member
  • Matthew W. Foehr, President and Chief Executive Officer
  • John Higgins, Board Chair
  • Steve Love, Chief Financial Officer

Last updated: 2024-12-31